跳至主要内容
临床试验/CTRI/2021/12/038430
CTRI/2021/12/038430已完成未知

A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF KSHEERABALA 101 AVARTHI AND KSHEERABALA THAILA IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY

Dr SHEMA SARA KURIE0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 METABOLICALLY STABLE DIABETIC SUBJECTS WITH SYMPTOMATIC DIABETIC PERIPHERAL NEUROPATHY
  • 2 SUBJECTS OF ALL GENDER BETWEEN THE AGE GROUP OF 20-75 YEARS
  • 3 SUBJECTS FULFILLING THE DIAGNOSTIC CRITERIA
  • 4 SUBJECTS WHOSE HBA1C IS BETWEEN 6.5 TO 10%

排除标准

  • 1 SUBJECTS WHERE HBA1C >10%
  • 2 SUBJECTS WITH OTHER CAUSES OF POLYNEUROPATHY OTHER THAN DIABETES
  • 3 SUBJECTS SUFFERING FROM INFECTIOUS DISEASES AND NON-HEALING ULCER/ ULCERS OF FOOT
  • 4 ANY SYSTEMIC ILLNESS THAT CAN INTERFERE WITH THE COURSE OF TREATMENT

研究者

发起方
Dr SHEMA SARA KURIE

相似试验